The Analyst Verdict: United Therapeutics In The Eyes Of 8 Experts
The Analyst Verdict: United Therapeutics In The Eyes Of 8 Experts
分析师评价：美国联合医疗在8位专家眼中的表现
A comprehensive examination of how financial...In the last three months, 8 analysts have published ratings on United Therapeutics (NASDAQ:UTHR), offering a diverse range of perspectives from bullish to bearish.
在过去的三个月中，8名分析师已经就美国联合医疗（纳斯达克：UTHR）发表了评级，提供了从看好到看淡的多样化观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $356.38, a high estimate of $400.00, and a low estimate of $280.00. Observing a 11.46% increase, the current average has risen from the previous average price target of $319.75.
分析师所分析的12个月价格目标提供了一些见解，平均目标为356.38美元，高估为400.00美元，低估为280.00美元。当前的平均价位较上一个平均价格目标的319.75美元上涨11.46%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
A comprehensive examination of how financial...
对金融专家如...
登录免费看全文
登录/注册
资讯热榜
更新时间